Gelatin methacryloyl biomaterials and strategies for trophoblast research
- PMID: 39341721
- PMCID: PMC11974609
- DOI: 10.1016/j.placenta.2024.09.016
Gelatin methacryloyl biomaterials and strategies for trophoblast research
Abstract
Rising maternal mortality rates in the U.S. are a significant public health issue that must be addressed; however, much of the basic science information required to target pregnancy-related pathologies have not yet been defined. Placental and blastocyst implantation research are challenging to perform in humans because of the early time frame of these processes in pregnancy and limited access to first trimester tissues. As a result, there is a critical need to develop model systems capable of studying these processes in increasing mechanistic detail. With the recent passing of the FDA Modernization Act 2.0 and advances in tissue engineering methods, three-dimensional microphysiological model systems offer an exciting opportunity to model early stages of placentation. Here, we detail the synthesis, characterization, and application of gelatin methacryloyl (GelMA) hydrogel platforms for studying trophoblast behavior in three-dimensional hydrogel systems. Photopolymerization strategies to fabricate GelMA hydrogels render the hydrogels homogeneous in terms of structure and stable under physiological temperatures, allowing for rigorous fabrication of reproducible hydrogel variants. Unlike other natural polymers that have minimal opportunity to tune their properties, GelMA hydrogel properties can be tuned across many axes of variation, including polymer degree of functionalization, gelatin bloom strength, light exposure time and intensity, polymer weight percent, photoinitiator concentration, and physical geometry. In this work, we aim to inspire and instruct the field to utilize GelMA biomaterial strategies for future placental research. With enhanced microphysiological models of pregnancy, we can now generate the basic science information required to address problems in pregnancy.
Keywords: Biomaterials; Gelatin; Tissue engineering; Trophoblast; Uteroplacental interface.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Samantha Zambuto reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels.Biomaterials. 2015 Dec;73:254-71. doi: 10.1016/j.biomaterials.2015.08.045. Epub 2015 Aug 28. Biomaterials. 2015. PMID: 26414409 Free PMC article. Review.
-
Evaluation of gelatin bloom strength on gelatin methacryloyl hydrogel properties.J Mech Behav Biomed Mater. 2024 Jun;154:106509. doi: 10.1016/j.jmbbm.2024.106509. Epub 2024 Mar 18. J Mech Behav Biomed Mater. 2024. PMID: 38518513
-
Protocols of 3D Bioprinting of Gelatin Methacryloyl Hydrogel Based Bioinks.J Vis Exp. 2019 Dec 21;(154). doi: 10.3791/60545. J Vis Exp. 2019. PMID: 31904016
-
Gelatin Methacrylate (GelMA)-Based Hydrogels for Cell Transplantation: an Effective Strategy for Tissue Engineering.Stem Cell Rev Rep. 2019 Oct;15(5):664-679. doi: 10.1007/s12015-019-09893-4. Stem Cell Rev Rep. 2019. PMID: 31154619 Review.
-
Cold Water Fish Gelatin Methacryloyl Hydrogel for Tissue Engineering Application.PLoS One. 2016 Oct 10;11(10):e0163902. doi: 10.1371/journal.pone.0163902. eCollection 2016. PLoS One. 2016. PMID: 27723807 Free PMC article.
References
-
- Souza JP, Day LT, Rezende-Gomes AC, Zhang J, Mori R, Baguiya A, Jayaratne K, Osoti A, Vogel JP, Campbell O, Mugerwa KY, Lumbiganon P, Tuncalp O, Cresswell J, Say L, Moran AC, Oladapo OT, A global analysis of the determinants of maternal health and transitions in maternal mortality, Lancet Glob. Health 12 (2024) e306–e316, 10.1016/S2214-109X(23)00468-0. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials